‘In­dia among top 10 for cargo’

Alexan­der Arafa, Head of Cargo Area & Con­tri­bu­tion Man­age­ment, Swiss WorldCargo, talks about the fu­ture plans of the com­pany while sharing the air­line's vi­sion for the In­dian mar­ket.

Cargo Talk - - Interview - CT BUREAU

How has the In­dian mar­ket evolved for the group?

In­dia is in the top 10 mar­kets from where we get suit­able cargo for Swiss WorldCargo. Since we are not grow­ing ca­pac­ity-wise, all we can do is to work more with the mix of the prod­ucts we carry out of In­dia. It is im­por­tant to note that pre­par­ing your bud­get is not only about hav­ing enough weight but also the type of freight we carry. That is why the idea is to grow in the pharma seg­ment, where there is a lot of po­ten­tial for growth. Our tar­get for In­dia is to look dif­fer­ent from other car­ri­ers be­cause we fly medium-sized air­crafts, A330.

What are your tar­gets for the Delhi mar­ket?

This is my first busi­ness trip to In­dia and I am very im­pressed with Delhi. The air­port is of­fer­ing sta­teof-the-art fa­cil­i­ties, be it in mea­sures of clean­li­ness, stor­age ca­pac­ity, ver­ti­cal ca­pa­bil­i­ties, and more. Delhi's fa­cil­ity is com­pa­ra­ble to what we have in Zurich and we are very proud on our ef­fi­cient and flex­i­ble Zurich hub.

I have found Delhi mar­ket quite ad-hoc com­pared to Mum­bai. Of late, we are get­ting high qual­ity busi­ness from here. Our part­ners are very pos­i­tive as far as the out­look is con­cerned. We want to jointly build the pharma seg­ment in the na­tional cap­i­tal. Nowa­days, we al­ready have a good mix of pharma, in­dus­trial goods, and en­gi­neer­ing goods out of Mum­bai, but we see less of pharma out of Delhi even with the ad­e­quate in­fra­struc­ture

Head of Cargo Area & Con­tri­bu­tion Man­age­ment, Swiss WorldCargo

in place. Pharma is one of Swiss WorldCargo's core com­pe­ten­cies and we do con­tin­u­ously fo­cus on evolv­ing our pharma busi­ness for Zurich, Switzer­land, and Brazil.

Why the dis­in­ter­est to fly Boe­ing777 from In­dia?

It is not dis­in­ter­est; it is all about de­ploy­ing right equip­ment for flown leg. Presently, we have eight Boe­ing777 in our net­work and two more are go­ing to ar­rive next year, pos­si­bly by April or May.

We de­ploy B777 mostly on ex­tra long-haul flights. In­dia is close enough to Zurich from where we serve with an A330, which takes care of the op­er­a­tional needs, thus al­low­ing us to de­ploy Boe­ing777 for longdis­tance des­ti­na­tions. For ex­am­ple, B777 air­craft flies on the North At­lantic, which ben­e­fits Delhi and Mum­bai as well be­cause both flights feed into Zurich. From there, the prod­ucts will be trans­ported on a B777 to Los An­ge­les, San Francisco, Chicago, and Mi­ami.

It is our tar­get for the In­dian mar­ket to dif­fer­en­ti­ate from the com­pe­ti­tion since we op­er­ate medium-sized air­craft and have a strongly ded­i­cated team there. Due to this rea­son, we will con­tin­u­ously con­cen­trate on the spe­cial seg­ment where we have proven records of our qual­ity ex­pe­ri­ence.

What is your USP?

We have a lean and ef­fi­cient team in In­dia, which al­lows op­ti­mal, close con­tact re­la­tion­ships with our cus­tomers and part­ners and more im­por­tantly, tuned to their re­quire­ments. We have a very good and knowl­edge­able team as we have in­vested a lot into their train­ing. Fur­ther, we look for tai­lor-made so­lu­tions for our part­ners as it is in our DNA to go the ex­tra mile.

Your vi­sion for five years down the line?

We would love to have more ca­pac­ity on our flights or even ad­di­tional flights to and from In­dia, as the coun­try is con­sis­tently do­ing re­ally well.

It would be nice for us to par­tic­i­pate in the growth. Fur­ther, there are some air­lines which are purely fly­ing do­mes­tic, with whom we al­ready have a good in­ter­line agree­ment to grow to­gether. See­ing the boom in the au­to­mo­tive mar­ket, we will look for an in­crease in share of au­to­mo­tive parts from OEMs, be­sides the pharma in­dus­try.

Pharma is one of our core com­pe­ten­cies and we do con­tin­u­ously fo­cus on evolv­ing our pharma busi­ness for Zurich, Switzer­land, and Brazil

Alexan­der Arafa

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.